Eye movement desensitization and reprocessing (EMDR) versus Cognitive behavioural therapy (CBT) in the treatment of Obsessive compulsive disorder (OCD)

Not Applicable

Completed

• Conditions: Obsessive-compulsive disorder; Obsessive Compulsive Disorder; Mental and Behavioural Disorders

• Registration Number: ISRCTN16396325
• Lead Sponsor: eeds Community Healthcare NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11-05
• Last Update Posted: 8 January 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients have been referred or signposted to an Improving Access to Psychological Therapies (IAPT) service in Leeds and are suitable for treatment in a primary care setting on the basis of:
1. Having a common mental disorder
2. Low risk of harm to self or others
Patients must meet ICD-10 diagnostic criteria for OCD, and this is the person's primary concern or reason for seeking treatment

Exclusion Criteria

This study is embedded in routine primary care mental health services, which specifically supports patients with common mental health problems
1. Patients with severe mental health problems are treated in psychiatric or secondary care mental health services, are routinely referred on to secondary care and therefore will not be recruited to this trial
2. Patients who are unsuitable for treatment in a primary care setting due to acute suicidal risk
3. Patients who meet criteria for alcohol or drug dependence (identified using a validated Severity of Dependence Scale)
4. Patients who do not currently meet diagnostic criteria for OCD as defined by the ICD-10
5. OCD is not the person's primary concern
6. Patients who are currently using prescribed benzodiazepines, which is a contra-indication to EMDR treatment. Potential participants using any other sedatives (e.g. opiates) will be interviewed by the study co-ordinator to determine whether the current dose may pose an obstacle to treatment (in consultation with the prescribing physician)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Self-rated Yale-Brown Obsessive Compulsive Scale (YBOCS) questionnaire<br>Measured at the beginning of every treatment sessions and at 6 months follow-up

Secondary Outcome Measures

Name	Time	Method
Routine IAPT measures: <br>1. Obsessive-Compulsive Inventory (OCI) (for obsessive compulsive symptoms)<br>2. Patient Health Questionnaire (PHQ9) (for depressive symptoms)<br>3. Generalized Anxiety Disorder (GAD7) (for anxiety symptoms)<br>4. Work and Social Adjustment Scale (WSAS) (measure of general functioning and adjustment)